Engineering Hepatitis B Virus (HBV) Protein Particles for Therapeutic Delivery

Methods Mol Biol. 2024;2720:115-126. doi: 10.1007/978-1-0716-3469-1_8.ABSTRACTNature provides an abundance of proteins whose structures and reactivity have been perfected through evolution to perform specific tasks necessary for biological function. The structural and functional properties of many natural proteins are quite valuable for the construction and customization of drug delivery vehicles. Self-assembling protein nanoparticle platforms are particularly useful scaffolds, as their multi-subunit designs allow the attachment of a high density of modifying molecules such as cell-binding ligands that provide avidity for targeting and facilitate encapsulation of large quantities of therapeutic payload. We explored SpyCatcher/SpyTag conjugation as a system to modify hepatitis B virus (HBV)-like particles (HBV VLPs). Using this simple decoration strategy, we demonstrated efficient and cell-selective killing of inflammatory breast cancer cells via delivery of yeast cytosine deaminase suicide enzymes combined with 5-fluoro-cytosine prodrugs.PMID:37775661 | DOI:10.1007/978-1-0716-3469-1_8
Source: Mol Biol Cell - Category: Molecular Biology Authors: Source Type: research